Three Benefits of Ordering Exome Testing as Trios
- Meghan Towne, MS, CGC, LCGC
- February 19, 2025
Exome sequencing, which assesses the protein coding sections of all ~20,000 genes, is an effective genetic test for a variety of clinical indications, but especially for children with neurodevelopmental disorders. Because the testing range is so broad, it is important to have as much supportive evidence as possible to efficiently identify clinically …
Read More
Why Consider an Exome-First Testing Workflow?
- February 4, 2025
The Power of Progress: Philip's NF1 Clinical Trial Experience
- Meagan Farmer
- May 22, 2024
We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …
Read More
